(Press-News.org) PHOENIX (May 20, 2023) – Today during the SCAI 2023 Scientific Sessions, thirty early-career interventional cardiologists were the inaugural recipients of a newly created award highlighting excellence in interventional cardiology. 30 in Their 30’s is a new recognition program created by the Society for
Cardiovascular Angiography & Interventions (SCAI) for early-career members for their proven leadership and demonstration of SCAI’s core values.
30 in Their 30’s recognizes the best and brightest young professionals in interventional cardiology. This award affirms their professional excellence and SCAI’s values of service and teamwork, and supports the next generation of SCAI members to continue their journey as interventional cardiology professionals on SCAI’s early-career member pathway.
Recipients of the first cohort include:
Janarthanan Sathananthan, MD – St. Paul’s Hospital/Vancouver General Hospital, Vancouver, BC, Canada
Aditya Bharadwaj, MD – Loma Linda University, Loma Linda, Calif.
Yader Sandoval, MD – Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN
Taisei Kobayashi, MD – Hospital of the University of Pennsylvania, Philadelphia, PA
Arash Salavitabar, MD – Nationwide Children’s Hospital, Columbus, OH
Abhishek Sharma, MD – Rutgers New Jersey Medical School, Newark, NJ
Karim Al-Azizi, MD – Baylor Scott & White Health – The Heart Hospital, Plano, TX
Yousif Ahmad, MD – Yale University, New Haven, CT
Brian Bergmark, MD – Brigham and Women’s Hospital, Boston, MA
Rhian Davies, MD – WellSpan Health, York, PA
Laura Davidson, MD – Northwestern University, Chicago, IL
Bibhu Mohanty, MD – University of South Florida, Tampa, FL
Devraj Sukul, MD – University of Michigan Health, Ann Arbor, MI
Arka Chatterjee, MD – Banner University Medical Center, Tucson, AZ
Jennifer Rymer, MD – Duke University School of Medicine, Durham, NC
Michael Young, MD – Dartmouth-Hitchcock Medical Center, Lebanon, NH
Rahul Sharma, MD – Stanford Medicine, Stanford, CA
Parasuram Melarcode Krishnamoorthy, MD – Mount Sinai Medical Center, New York, NY
Sinjini Biswas, MD – Bristol Heart Institute, Bristol, United Kingdom
Lawrence Ang, MD – UC San Diego Health, San Diego, Calif.
Mir Basir, MD – Henry Ford Hospital, Detroit, MI
Fredy El Sakr, MD – Northside Hospital Cardiovascular Institute, Atlanta, GA
Khanjan Shah, MD – University of Florida, Gainesville, FL
Giorgio Medranda, MD – NYU Langone Hospital – Long Island, Long Island, NY
Jared O'Leary, MD – Vanderbilt University Medical Center, Nashville, TN
Sadip Pant, MD – Prima Care, Fall River, MA
Samit Shah, MD – Yale School of Medicine, New Haven, CT
Miguel Alvarez Villela, MD – Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
Rafael Harari, MD – New York University Medical Center, New York, NY
Pedro Villablanca, MD – Henry Ford Hospital, Detroit, MI
“We are proud to honor and recognize this talented group interventional cardiologists with this new award,” said SCAI President George D. Dangas, MD, PhD, MSCAI. “Their notable contributions to both SCAI and our specialty at such an early point in their careers shows their dedication to advancing patient care and represents the future of our organization. We are excited to have them continue to be impactful contributors as SCAI members and future leaders of the profession.”
###
About SCAI
The Society for Cardiovascular Angiography & Interventions (SCAI) is a non-profit professional associationwith over 4,500 members representing interventional cardiologists and cardiac catheterization teams in the United States. SCAI promotes excellence in interventional cardiovascular medicine for both adults and children through education, representation, and the advancement of quality standards to enhance patient
care. Follow @SCAI on Twitter for the latest heart health news.
END
SCAI announces new award recognizing the contributions of early career interventional cardiologists
30 in Their 30’s will celebrate interventional cardiology’s future leaders
2023-05-21
ELSE PRESS RELEASES FROM THIS DATE:
Society for Cardiovascular Angiography and Interventions bestows highest designation ranking to leading interventional cardiologists
2023-05-21
PHOENIX (May 20, 2023) – Today, the Society for Cardiovascular Angiography & Interventions (SCAI) announced its 2023 Master Interventionalists of SCAI (MSCAI) designation recipients during the SCAI 2023 Scientific Sessions in Phoenix.
The MSCAI designation is awarded to individuals who have demonstrated excellence in invasive/interventional cardiology over the course of their career and for their commitment to the highest levels of clinical care, innovation, publication, and teaching.
This year’s MSCAI designations were awarded to the following group of outstanding interventionalists:
David ...
HRS, APHRS, and LAHRS release cardiac physiological pacing guideline
2023-05-20
New Orleans, May 20, 2023 – Today, the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Latin American Heart Rhythm Society (LAHRS) released a new clinical practice guideline on cardiac physiologic pacing (CPP) strategies to restore ventricular synchrony and improve cardiac performance. The 2023 HRS/APHRS/LAHRS Guideline on Cardiac Physiologic Pacing for the Avoidance and Mitigation of Heart Failure is intended to provide guidance to clinical cardiac electrophysiologists, cardiologists, and other clinicians on the use of CPP, which includes cardiac resynchronization therapy and conduction system pacing, in patients ...
Tokyo Tech and HPE collaborate to build the next generation TSUBAME4.0 supercomputer for artificial intelligence, scientific research, and innovation
2023-05-20
Tokyo Institute of Technology (Tokyo Tech) Global Scientific Information and Computing Center (GSIC) and Hewlett Packard Enterprise (NYSE: HPE) announced to build its next-generation supercomputer, TSUBAME4.0, to accelerate AI-driven scientific discovery in medicine, materials science, climate research, and turbulence in urban environments.
Tokyo Tech is one of the world's leading universities in science and technology. With the TSUBAME4.0 supercomputer, users will have the ability to train ...
Heart attack patients with strong legs have better prognosis
2023-05-20
Prague, Czechia – 20 May 2023: People with strong legs are less likely to develop heart failure after a heart attack, according to research presented today at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC).1
Myocardial infarction is the most common cause of heart failure,2 with around 6–9% of heart attack patients going on to develop the condition.3,4 Previous research has shown that having strong quadriceps is associated with a lower risk of death in patients with coronary artery disease.5
This study tested ...
Remote monitoring reduces heart failure hospitalizations and improves quality of life
2023-05-20
Prague, Czechia – 20 May 2023: The first investigator-initiated study of remote pulmonary artery pressure monitoring has found that it improves quality of life and reduces heart failure hospitalisations in patients with chronic heart failure. The findings are presented today in a late breaking science session at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC),1 and published in The Lancet.
Principal investigator Dr. Jasper Brugts of Erasmus University Medical Centre, ...
A Spanish team presents the first pharmacological treatment able to improve cardiac function in stiff-heart syndrome
2023-05-20
Transthyretin-related cardiac amyloidosis is a progressive disease characterized by the deposition of amyloid protein fibrils in the heart. Amyloid fibril deposition thickens and stiffens the heart walls, and the disease is also known as stiff-heart syndrome. The accumulation of amyloid fibrils causes heart failure, and patients suffer from fluid retention, fatigue, and arrhythmias. The disease can be caused by genetic mutations or related to aging. Prognosis is poor, and untreated patients survive for an average of just 3 years.
Now, the ...
George Dangas, MD, Ph.D., named President of Society for Cardiovascular Angiography & Interventions
2023-05-20
The Society for Cardiovascular Angiography & Interventions (SCAI) has named George Dangas, MD, PhD, Professor of Medicine (Cardiology), and Surgery, at the Icahn School of Medicine at Mount Sinai as its new President. He was appointed on Saturday, May 20, during the closing ceremonies at the SCAI 2023 Scientific Sessions in Phoenix. He is the first Mount Sinai cardiologist to hold this position and will serve as the 46th President of SCAI.
Dr. Dangas, also the Director of Cardiovascular Innovation at the Zena and Michael A. Wiener Cardiovascular Institute at Icahn Mount Sinai and Chief of Cardiology ...
Forging partnerships in the Americas: Naval leaders gather at SIANC S&T Conference
2023-05-20
ARLINGTON, Va.—For Dr. Brett Seidle — the deputy assistant secretary of the Navy for Research, Development, Test and Engineering — the breakneck speed of current scientific progress and technological proliferation can be challenging, especially when the impact of new technologies on civilian and military realities transcends national borders.
While giving the keynote address at the recent Specialized Inter-American Naval Conference on Science, Technology and Innovation (SIANC-ST&I) in Orlando, Florida, Seidle identified several scientific disciplines that have developed into ...
New study reveals possible future health impacts related to climate mitigation
2023-05-20
UNIVERSITY PARK, Pa. — Reduce fossil fuel use and air quality will improve, right? It might not be as straightforward as it appears, according to a Penn State-led research team. They explored almost 30,000 simulated future scenarios and found that some climate mitigation efforts could lead to harmful health impacts in certain geographic areas.
Their results were published today (May 18) in Nature Sustainability.
“In general, reducing fossil fuel use is good for climate mitigation and good for cleaning up the air, and the modeling studies have always found health benefits from climate mitigation,” said corresponding ...
Study finds cardiovascular risk score improves after one year of semaglutide use in patients with overweight and obesity
2023-05-20
New research presented at this year’s European Congress on Obesity in Dublin, Ireland shows that patients treated with the obesity drug semaglutide have a decreased cardiovascular risk score after one year of use. The study is by Dr Andres Acosta and Dr Wissam Ghusn, Precision Medicine for Obesity Program at the Mayo Clinic, Rochester, MN, USA and colleagues.
Obesity is a major risk factor for the development of abnormal blood fat levels, type-2 diabetes mellitus (T2DM), high blood pressure, and obstructive sleep apnoea. These comorbidities are associated with an increased risk of cardiovascular disease (CVD) that represents ...
LAST 30 PRESS RELEASES:
American Academy of Sleep Medicine announces 2025 award recipients
Scientists define the ingredients for finding natural clean hydrogen
New study sheds light on health differences between sexes
Scientists film the heart forming in 3D earlier than ever before
Astrophysicists explore our galaxy’s magnetic turbulence in unprecedented detail using a new computer model
Scientists precisely simulate turbulence in the Galaxy — it doesn’t behave like they thought
DiffInvex reveals how cancers rewire driver genes to beat chemotherapy
Combinations of chronic illnesses could double risk of depression
Growth before photosynthesis: how trees regulate their water balance
Stress hormone pathways in primate brains reveal key insights for human mental health research
Enlarged salience network could be first reliable biomarker for depression risk
Higher success rate using a simple oral swab test before IVF
New survey shows privacy and safety tops list of parental concerns about screen time
Enhanced activity in the upper atmosphere of Sporadic E layers during the 2024 Mother’s Day super geomagnetic storm
Accelerating bacterial evolution in the laboratory
Summer in the city
Echidna microbiome changes while mums nurse puggle
No increased risk of gynecological cancer with testosterone use after five years
Growth in informal lead mining is contributing to widespread poisoning
Unprecedented progress in tackling smoking during pregnancy threatened by NHS cuts, experts warn
Top scientific research recognized at ACC Asia Conference
GLP-1 drugs are helpful for children who are living with severe obesity, data from Swedish clinic indicates
Popular weight-loss drugs following bariatric surgery may offer additional cardiovascular benefits
Patients of an online obesity clinic achieved the same weight loss as those in clinical trials of semaglutide – but with much lower doses of the drug
Protein bars enriched with collagen have potential as a weight-loss aid, Spanish study finds
Semaglutide may provide early protection against heart disease in high-risk patients—even before clinically meaningful weight loss and prior to the full target dose
Civil defense units must invest in professionalization and own resources to face climate risks
Flamingos create water tornados to trap their prey
FFAR taps Danforth Center plant scientists for crop research to preserve soil and water health
Research spotlight: ‘Cell line atlas’ provides a crucial resource for developing therapies for biliary tract cancer
[Press-News.org] SCAI announces new award recognizing the contributions of early career interventional cardiologists30 in Their 30’s will celebrate interventional cardiology’s future leaders